EPI Übernahme - Wir halten zusammen

Big News from New Day Diagnostics!
We’re proud to announce the nationwide launch of ColoHealth our FDA-cleared blood test for colorectal cancer screening, now available for physician ordering across the U.S.

ColoHealth is a game-changer in early detection—simple, accurate, non-invasive—and empowers providers to offer patients a more accessible screening option.

Read the official press release to learn more: https://loom.ly/rvEjfw8  

loom.ly/rvEjfw8  

Oh  kommt das was  

Dickes Plus  

NDD ist dran am next-gen Test der von Epigenomics übernommen wurde. Mal sehen…….


„At ADLM 2025, meet us at the Luminex booth ) where we’ll be talking about how the Luminex ELISA platform powers our work- from developing ColoPlex Plus  a next-gen blood test for early colorectal cancer detection, to designing custom assays for diagnostics developers.

Through New Day Bioresearch, we offer contract research services that help bring your vision to life- from assay design to analytical validation.

If you're building a better test, let's talk.“